BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11643749)

  • 1. Researcher denied future U.S. funds.
    Broad WJ
    Science; 1982 Jun; 216(4550):1081. PubMed ID: 11643749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHS publishes final debarment regulations.
    Levine C
    IRB; 1980 Nov; 2(9):10. PubMed ID: 11661885
    [No Abstract]   [Full Text] [Related]  

  • 3. Data audit by a regulatory agency: its effect and implication for others.
    Shapiro MF
    Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
    [No Abstract]   [Full Text] [Related]  

  • 4. Innovation and integrity in biomedical research.
    Jasanoff S
    Acad Med; 1993 Sep; 69(9 Suppl):S91-5. PubMed ID: 11652808
    [No Abstract]   [Full Text] [Related]  

  • 5. Barred researcher publishes a paper.
    Sun M
    Science; 1983 Jan; 219(4582):270. PubMed ID: 11644000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
    Nightingale SL
    Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
    [No Abstract]   [Full Text] [Related]  

  • 7. Scientist ousted from cancer study declines to testify to House panel.
    Altman LK
    N Y Times Web; 1994 Apr; ():C1, C3. PubMed ID: 11647971
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal policy for the protection of human subjects; notice and proposed rules.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1988 Nov; 53(218):45660-82. PubMed ID: 11645617
    [No Abstract]   [Full Text] [Related]  

  • 9. Criminal liability for misconduct in scientific research.
    Kuzma SM
    Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
    [No Abstract]   [Full Text] [Related]  

  • 10. Fraud inquiry spreads blame.
    Culliton BJ
    Science; 1983 Feb; 219(4587):937. PubMed ID: 11643955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A doctor's drug studies turn into fraud.
    Eichenwald K; Kolata G
    N Y Times Web; 1999 May; ():A1, A16. PubMed ID: 11647660
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientific misconduct: undue process.
    Efron R
    Account Res; 1993; 3(2-3):223-38. PubMed ID: 11652297
    [No Abstract]   [Full Text] [Related]  

  • 13. Illmensee faces funding cutoff.
    Norman C
    Science; 1984 Apr; 224(4646):265. PubMed ID: 11644124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsibilities of awardee and applicant institutions for dealing with and reporting possible misconduct in science; final rule.
    US Public Health Service
    Fed Regist; 1989 Aug; 54(151):32446-51. PubMed ID: 11651184
    [No Abstract]   [Full Text] [Related]  

  • 15. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
    Siris ES; Burrell CD
    IRB; 1983; 5(6):1-5. PubMed ID: 11649526
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart researcher penalised for fixing results.
    New Sci; 1983 Feb; 97(1345):426. PubMed ID: 11655506
    [No Abstract]   [Full Text] [Related]  

  • 17. Probe into flawed cancer study.
    Altman LK
    N Y Times Web; 1994 Apr; ():C3. PubMed ID: 11647029
    [No Abstract]   [Full Text] [Related]  

  • 18. Too good to be true.
    Colt GH
    Harv Mag; 1983; 85(6):22-28, 54. PubMed ID: 11649472
    [No Abstract]   [Full Text] [Related]  

  • 19. Cline stripped of research grants.
    Dickson D
    Nature; 1981 Dec; 294(5840):391-2. PubMed ID: 11643675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harvard researcher draws heavy penalty for faking results.
    Med World News; 1983 Mar; 24(5):48-50. PubMed ID: 11653447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.